Home · Health · Sep 20 archive

Common Drugs May Be Overused in Older Adults

Confirmed

Health Desk

In Short: Medical researchers are investigating the overuse of certain drugs among older adults, suggesting that benzodiazepines and HIV medications may pose significant risks.

According to the American Geriatrics Society, benzodiazepines like Valium, Xanax, and Ativan, as well as related 'Z' drugs such as Ambien and Lunesta, may impair balance, coordination, and cognition, leading to falls, fractures, and motor vehicle accidents.

The scenario often begins with medical researchers discovering that a commonly used drug is less effective for older patients or that its risks outweigh its benefits.

Aging individuals with HIV face unique challenges, including combined stigma from age and HIV status, and delayed treatment, particularly among those aged 50 or older.

The report's authors note that older individuals living with HIV often hesitate to disclose sexual activity due to ageist stereotypes and stigma, complicating their care.

By 2025, an estimated 11.5 million individuals aged 50 years or older will be living with HIV, accounting for 29% of the global population living with HIV.

Nearly all older adults (96%) are expected to live in low-income and middle-income countries, presenting both clinical and social challenges.

Older adults living with HIV commonly have multiple coexisting conditions, complicating their care and treatment.

Healthcare providers and family members should be vigilant about changes in an older person’s routine, as symptoms like fatigue, breathlessness, and difficulty carrying out daily activities can be early warning signs of serious conditions.

What this adds

This report adds new insights into the challenges faced by older adults with HIV and the potential risks of overusing certain medications, expanding on prior WarpBeat coverage of drug overuse in older adults.

Background

New reports highlight the overuse of certain drugs among older adults, including benzodiazepines and HIV medications.

What's confirmed

What's still developing

Sources